Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-29 Purchase |
2025-01-31 5:54 pm |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT |
10,040 | $5.1548 | $51,754 | 444,259 (Direct) |
View |
| 2025-01-27 Purchase |
2025-01-29 6:15 pm |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT |
9,542 | $5.2717 | $50,303 | 674,219 (Direct) |
View |
| 2024-09-12 Purchase |
2024-09-13 5:43 pm |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT |
14,815 | $5.0867 | $75,359 | 384,677 (Direct) |
View |
| 2024-09-10 Purchase |
2024-09-12 7:06 pm |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT |
5,000 | $4.97 | $24,850 | 369,862 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Szela Mary T Director |
2,071 | $0 | $0 | 0 (Direct) |
View |
| 2020-06-22 Sale |
2020-06-24 4:55 pm |
Coherus BioSciences Inc. | CHRS | Szela Mary T Director |
54,997 | $17.58 | $966,759 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Option Award |
2025-02-19 5:41 pm |
N/A N/A |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT |
21,089 | $0 | 465,348 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 6:15 pm |
N/A 2035-01-26 |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT |
280,000 | $0 | 674,219 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:20 pm |
N/A 2034-06-19 |
Omega Therapeutics Inc. | OMGA | Szela Mary T Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Kura Oncology Inc. | KURA | Szela Mary T Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-14 6:44 pm |
N/A 2034-02-12 |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT |
373,649 | $0 | 653,612 (Direct) |
View |
| 2023-08-14 Option Award |
2023-08-15 4:48 pm |
N/A 2033-08-13 |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President |
172,500 | $0 | 172,500 (Direct) |
View |
Ownership |
2023-08-15 4:46 pm |
N/A N/A |
TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President |
0 | $0 | 906,895 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:05 pm |
N/A 2033-06-06 |
Omega Therapeutics Inc. | OMGA | Szela Mary T Director |
18,118 | $0 | 18,118 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 5:02 pm |
N/A 2033-05-30 |
Kura Oncology Inc. | KURA | Szela Mary T Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:47 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Szela Mary T Director |
2,071 | $0 | 2,071 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-23 4:49 pm |
N/A 2032-06-20 |
Kura Oncology Inc. | KURA | Szela Mary T Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:10 pm |
N/A 2032-06-07 |
Omega Therapeutics Inc. | OMGA | Szela Mary T Director |
18,118 | $0 | 18,118 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 7:30 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | Szela Mary T Director |
20,500 | $0 | 20,500 (Direct) |
View |
Ownership |
2021-07-29 9:01 pm |
N/A 2029-09-16 |
Omega Therapeutics Inc. | OMGA | Szela Mary T Director |
0 | $0 | 83,826 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:19 pm |
N/A 2031-06-21 |
Kura Oncology Inc. | KURA | Szela Mary T Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-11 9:47 pm |
N/A 2031-03-10 |
Prometheus Biosciences Inc. | RXDX | Szela Mary T Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-13 4:29 pm |
N/A 2031-01-11 |
Coherus BioSciences Inc. | CHRS | Szela Mary T Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-24 Option Award |
2020-06-26 4:10 pm |
N/A 2030-06-23 |
Kura Oncology Inc. | KURA | Szela Mary T Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-24 4:55 pm |
N/A 2024-06-30 |
Coherus BioSciences Inc. | CHRS | Szela Mary T Director |
54,997 | $0 | 0 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-24 4:55 pm |
N/A N/A |
Coherus BioSciences Inc. | CHRS | Szela Mary T Director |
20,000 | $12.37 | 0 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-24 4:55 pm |
N/A N/A |
Coherus BioSciences Inc. | CHRS | Szela Mary T Director |
20,000 | $10.05 | 0 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-24 4:55 pm |
N/A N/A |
Coherus BioSciences Inc. | CHRS | Szela Mary T Director |
14,997 | $2.5005 | 0 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:18 pm |
N/A 2030-06-17 |
ALIMERA SCIENCES INC | ALIM | Szela Mary T Director |
3,333 | $0 | 3,333 (Direct) |
View |